QNCX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

QNCXQuince Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

QNCXQuince Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

QNCXQuince Therapeutics, Inc.

33.00▼−1.64%· post 33.00

Mkt cap$34.1MRevenue—Revenue—

AMGNAmgen Inc

460.67▼−1.03%· post 456.16

ClosedNov 3 '26

Mkt cap$249.4BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

ClosedNov 3 '26

QNCXQuince Therapeutics, Inc.

AMGNAmgen Inc

33.00▼−1.64%post 33.00

Price

460.67▼−1.03%post 456.16

$34.1M

Mkt cap

$249.4B

—

Revenue

$10.1BQ2 FY26

—

Revenue

$36.8BFY25

QNCX33.00▼−1.64%vsAMGN460.67▼−1.03%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

QNCX, solidAMGN, dashed

Supply-chain overlap

Revenue flow

QNCX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only QNCX 0

None

Shared 0

No disclosed counterparties: QNCX.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Role chip = supplier or customerSource: SEC EDGAR